105 related articles for article (PubMed ID: 25554469)
1. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.
Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D
Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469
[TBL] [Abstract][Full Text] [Related]
2. Inhalation of Respirable Crystalline Rifapentine Particles Induces Pulmonary Inflammation.
Parumasivam T; Ashhurst AS; Nagalingam G; Britton WJ; Chan HK
Mol Pharm; 2017 Jan; 14(1):328-335. PubMed ID: 27977216
[TBL] [Abstract][Full Text] [Related]
3. A novel inhalable form of rifapentine.
Chan JG; Duke CC; Ong HX; Chan JC; Tyne AS; Chan HK; Britton WJ; Young PM; Traini D
J Pharm Sci; 2014 May; 103(5):1411-21. PubMed ID: 24585270
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Weiner M; Bock N; Peloquin CA; Burman WJ; Khan A; Vernon A; Zhao Z; Weis S; Sterling TR; Hayden K; Goldberg S;
Am J Respir Crit Care Med; 2004 Jun; 169(11):1191-7. PubMed ID: 14962821
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment.
Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK
Eur J Pharm Biopharm; 2016 Oct; 107():205-14. PubMed ID: 27422209
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy.
Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK
Mol Pharm; 2016 Mar; 13(3):979-89. PubMed ID: 26808409
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of rifapentine in children.
Blake MJ; Abdel-Rahman SM; Jacobs RF; Lowery NK; Sterling TR; Kearns GL
Pediatr Infect Dis J; 2006 May; 25(5):405-9. PubMed ID: 16645503
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
[TBL] [Abstract][Full Text] [Related]
9. Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.
Conte JE; Golden JA; McQuitty M; Kipps J; Lin ET; Zurlinden E
Antimicrob Agents Chemother; 2000 Apr; 44(4):985-90. PubMed ID: 10722501
[TBL] [Abstract][Full Text] [Related]
10. The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.
Sirgel FA; Fourie PB; Donald PR; Padayatchi N; Rustomjee R; Levin J; Roscigno G; Norman J; McIlleron H; Mitchison DA
Am J Respir Crit Care Med; 2005 Jul; 172(1):128-35. PubMed ID: 15805182
[TBL] [Abstract][Full Text] [Related]
11. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
[TBL] [Abstract][Full Text] [Related]
12. A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.
Chan JG; Tyne AS; Pang A; Chan HK; Young PM; Britton WJ; Duke CC; Traini D
Pharm Res; 2014 May; 31(5):1239-53. PubMed ID: 24242939
[TBL] [Abstract][Full Text] [Related]
13. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach.
Patil-Gadhe A; Pokharkar V
Pulm Pharmacol Ther; 2014 Apr; 27(2):197-207. PubMed ID: 23916767
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.
Khadka P; Sinha S; Tucker IG; Dummer J; Hill PC; Katare R; Das SC
Eur J Pharm Biopharm; 2021 May; 162():1-11. PubMed ID: 33639255
[TBL] [Abstract][Full Text] [Related]
15. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
Alfarisi O; Alghamdi WA; Al-Shaer MH; Dooley KE; Peloquin CA
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1027-1036. PubMed ID: 28803492
[TBL] [Abstract][Full Text] [Related]
16. Rifapentine for the treatment of tuberculosis: is it all it can be?
Gordin FM
Am J Respir Crit Care Med; 2004 Jun; 169(11):1176-7. PubMed ID: 15161608
[No Abstract] [Full Text] [Related]
17. Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis.
Langdon G; Wilkins JJ; Smith PJ; McIlleron H
Int J Tuberc Lung Dis; 2004 Jul; 8(7):862-7. PubMed ID: 15260278
[TBL] [Abstract][Full Text] [Related]
18. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.
Savic RM; Weiner M; MacKenzie WR; Engle M; Whitworth WC; Johnson JL; Nsubuga P; Nahid P; Nguyen NV; Peloquin CA; Dooley KE; Dorman SE;
Clin Pharmacol Ther; 2017 Aug; 102(2):321-331. PubMed ID: 28124478
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects.
Winter H; Egizi E; Murray S; Erondu N; Ginsberg A; Rouse DJ; Severynse-Stevens D; Pauli E
Antimicrob Agents Chemother; 2015 Feb; 59(2):1219-24. PubMed ID: 25512422
[TBL] [Abstract][Full Text] [Related]
20. Rifapentine: its role in the treatment of tuberculosis.
Temple ME; Nahata MC
Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
